HeraMED is a medical data and technology company leading the digital transformation of maternity care with state-of-the-art technology and human-centered experience design.

We are committed to reimagining the way maternity care is delivered and experienced for pregnant people, their support teams, and care companions worldwide. HeraMED aims to improve maternal health equity and access to quality prenatal care for expectant moms everywhere by developing technology that powers better pregnancy outcomes and fosters healthier pregnancies globally.

HeraMED connects need and care by creating personalized maternity journeys and clinically designed care plans that deliver actionable information to all members of the care continuum, ensuring they are informed, empowered, and safe.

HeraMED offers innovative products including HeraBEAT, a medically accurate, smartphone-based in-home fetal and maternal heart rate monitor, and HeraCARE, an end-to-end digital maternity monitoring and management platform. HeraCARE facilitates a hybrid care model that enables remote monitoring of vital signs such as blood pressure, weight, fetal heart rate, and mood, providing proactive and personalized maternity care. The platform includes features like 24/7 access to educational content, lifestyle guidance, pregnancy management tools, and support for patients and providers.

HeraMED's technology is medically validated and has been recognized by top medical institutions worldwide, including collaborations with the Mayo Clinic and Sheba Medical Center. The company continues to invest in research and development to advance its home-oriented monitoring technology.

- Melbourne, Australia

- Netanya, Israel

CEO: Anoushka Gungadin

CMO: Dr. Arturo Weschler MD

CFO & Company Secretary: Cameron Jones

Director of Operations: Nir Pearl